Spleen News and Research

RSS
Injured nerves may cause severe pain in patients with sickle cell disease

Injured nerves may cause severe pain in patients with sickle cell disease

ITCH gene causes multisystem autoimmune disorder

ITCH gene causes multisystem autoimmune disorder

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Gaucher disease: FDA approves VPRIV

Gaucher disease: FDA approves VPRIV

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

Six states to study sickle cell disease and thalassemias in national pilot project

Six states to study sickle cell disease and thalassemias in national pilot project

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented

Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented

Researchers discover new target for drugs to prevent common iron deficiency

Researchers discover new target for drugs to prevent common iron deficiency

GEH to create a supply of molybdenum-99 for use in nuclear medicine diagnostic procedures

GEH to create a supply of molybdenum-99 for use in nuclear medicine diagnostic procedures

GSK receives European CHMP positive opinion for Revolade

GSK receives European CHMP positive opinion for Revolade

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

Retrospective study demonstrates new survival data for patients with myelofibrosis

Retrospective study demonstrates new survival data for patients with myelofibrosis

JAK2 inhibitor can control myelofibrosis, report researchers

JAK2 inhibitor can control myelofibrosis, report researchers

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

EMEA grants orphan drug status for LFB Biotechnologies' recombinant anti-CD20 monoclonal antibody

EMEA grants orphan drug status for LFB Biotechnologies' recombinant anti-CD20 monoclonal antibody

New initiative launched to take care of patients with sickle cell disease

New initiative launched to take care of patients with sickle cell disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.